LONDON, 12th July 2019 – WINCHESTER MD LIMITED (“Winchester” or the “Company”) is pleased to announce that it was lead sponsor and an exhibitor at the Inaugural Institutional Capital & Cannabis Conference (Europe) in London.
IC3 forums are a meeting place for investors who wish to learn more about cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
IC3 conferences have earned a reputation in the US for quality content, expert speakers, and a high representation of institutional investors among its delegates. Winchester’s co-founder, Dan Kriznic, and its legal counsel, Fraser McGee both sat on industry expert panels and CEO, Faz Moshfeghi, was interviewed on stage in a strategic session led by Tristan Gervais, the London leader of Canaccord Genuity’s Cannabis sector team.
Faz Moshfeghi, CEO of Winchester MD commented: “We are delighted both with the new contacts we made at IC3 and with the positive feedback from investors and industry stakeholders on our exciting expansion strategy to build on our profitable UK on-line cannabis superstore”.
For more information, please visit www.winchestermd.com
On Behalf of the Board,
About Winchester MD Limited
Winchester MD is a vertically integrated European cannabis company based out of London, UK. The Company was founded in 2018 with an initial focus on CBD Wellness through a revenue producing online retail superstore platform. The Company offers a variety of CBD branded products through its on line superstore and continues to develop and market new products in the CBD Wellness category. In 2019 the Company has expanded into other verticals in the cannabis sector with the vision of becoming a global cannabis leader with cultivation, extraction, CBD wellness and research and development.